Characterization of co-amorphous carvedilol–maleic acid system prepared by solvent evaporation

References

• Alleso M, Chieng N, Rehder S, Rantanen J, Rades T, Aaltonen J. 2009. Enhanced dissolution rate and synchronized release of drugs in binary systems through formulation: amorphous naproxen-cimetidine mixtures prepared by mechanical activation. J Control Release. 136(1):45–53.
   PubMed Web of Science ®Google Scholar
• Ambike AA, Mahadik KR, Paradkar A. 2004. Stability study of amorphous valdecoxib. Int J Pharm. 282(1-2):151–162.
   PubMed Web of Science ®Google Scholar
• Arzani G, Haeri A, Daeihamed M, Bakhtiari-Kaboutaraki H, Dadashzadeh S. 2015. Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge. Int J Nanomed. 10:4797–4813.
   PubMed Web of Science ®Google Scholar
• Babu NJ, Nangia A. 2011. Solubility advantage of amorphous drugs and pharmaceutical cocrystals. Cryst Growth Des. 11(7):2662–2679.
   Web of Science ®Google Scholar
• Brough C, Williams RO 3rd. 2013. Amorphous solid dispersions and nano-crystal technologies for poorly water-soluble drug delivery. Int J Pharm. 453(1):157–166.
   PubMed Web of Science ®Google Scholar
• Chakraborty S, Shukla D, Jain A, Mishra B, Singh S. 2009. Assessment of solubilization characteristics of different surfactants for carvedilol phosphate as a function of pH. J Colloid Interface Sci. 335(2):242–249.
   PubMed Web of Science ®Google Scholar
• Chauhan B, Shimpi S, Paradkar A. 2005. Preparation and evaluation of glibenclamide-polyglycolized glycerides solid dispersions with silicon dioxide by spray drying technique. Euro J Pharm Sci. 26(2):219–230.
   PubMed Web of Science ®Google Scholar
• Chavan RB, Thipparaboina R, Kumar D, Shastri NR. 2016. Co amorphous systems: a product development perspective. Int J Pharm. 515(1-2):403–415.
   PubMed Web of Science ®Google Scholar
• Chieng N, Aaltonen J, Saville D, Rades T. 2009. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation. Eur J Pharm Biopharm. 71(1):47–54.
   PubMed Web of Science ®Google Scholar
• Dengale SJ, Grohganz H, Rades T, Lobmann K. 2016. Recent advances in co-amorphous drug formulations. Adv Drug Deliv Rev. 100:116–125.
   PubMed Web of Science ®Google Scholar
• Dengale SJ, Ranjan OP, Hussen SS, Krishna BS, Musmade PB, Gautham Shenoy G, Bhat K. 2014. Preparation and characterization of co-amorphous Ritonavir-Indomethacin systems by solvent evaporation technique: improved dissolution behavior and physical stability without evidence of intermolecular interactions. Eur J Pharm Sci. 62:57–64.
   PubMed Web of Science ®Google Scholar
• Gao Y, Liao J, Qi X, Zhang J. 2013. Coamorphous repaglinide-saccharin with enhanced dissolution. Int J Pharm. 450(1-2):290–295.
   PubMed Web of Science ®Google Scholar
• Gupta MK, Tseng YC, Goldman D, Bogner RH. 2002. Hydrogen bonding with adsorbent during storage governs drug dissolution from solid-dispersion granules. Pharm Res. 19(11):1663–1672.
   PubMed Web of Science ®Google Scholar
• Heinz A, Strachan CJ, Gordon KC, Rades T. 2009. Analysis of solid-state transformations of pharmaceutical compounds using vibrational spectroscopy. J Pharm Pharmacol. 61(8):971–988.
   PubMed Web of Science ®Google Scholar
• Hirlekar R, Kadam V. 2009. Preparation and characterization of inclusion complexes of carvedilol with methyl-β-cyclodextrin. J Incl Phenom Macrocycl Chem. 63(3-4):219–224.
   Web of Science ®Google Scholar
• Huang Y, Zhang Q, Wang JR, Lin KL, Mei X. 2017. Amino acids as co-amorphous excipients for tackling the poor aqueous solubility of valsartan. Pharm Dev Technol. 22(1):69–76.
   PubMed Web of Science ®Google Scholar
• Jensen KT, Larsen FH, Cornett C, Lobmann K, Grohganz H, Rades T. 2015. Formation mechanism of coamorphous drug-amino acid mixtures. Mol Pharm. 12(7):2484–2492.
   PubMedGoogle Scholar
• Li J, Guo Y, Zografi G. 2002. The solid-state stability of amorphous quinapril in the presence of beta-cyclodextrins. J Pharm Sci. 91(1):229–243.
   PubMed Web of Science ®Google Scholar
• Lobmann K, Grohganz H, Laitinen R, Strachan C, Rades T. 2013. Amino acids as co-amorphous stabilizers for poorly water soluble drugs–part 1: preparation, stability and dissolution enhancement. Eur J Pharm Biopharm. 85(3 Pt B):873–881.
   PubMed Web of Science ®Google Scholar
• Lobmann K, Laitinen R, Grohganz H, Gordon KC, Strachan C, Rades T. 2011. Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen. Mol Pharm. 8(5):1919–1928.
   PubMed Web of Science ®Google Scholar
• McTavish D, Campoli-Richards D, Sorkin EM. 1993. Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs. 45(2):232–258.
   PubMed Web of Science ®Google Scholar
• Planinsek O, Kovacic B, Vrecer F. 2011. Carvedilol dissolution improvement by preparation of solid dispersions with porous silica. Int J Pharm. 406(1-2):41–48.
   PubMedGoogle Scholar
• Potluri RH, Bandari S, Jukanti R, Veerareddy PR. 2011. Solubility enhancement and physicochemical characterization of carvedilol solid dispersion with Gelucire 50/13. Arch Pharm Res. 34(1):51–57.
   PubMed Web of Science ®Google Scholar
• Ruponen M, Kettunen K, Santiago Pires M, Laitinen R. 2021. Co-amorphous formulations of furosemide with arginine and p-glycoprotein inhibitor drugs. Pharmaceutics. 13(2):171.
   PubMed Web of Science ®Google Scholar
• Shayanfar A, Ghavimi H, Hamishekar H, Jouyban A. 2013. Coamorphous atorvastatin calcium to improve its physicochemical and pharmacokinetic properties. J Pharm Pharm Sci. 16(4):577–587.
   PubMed Web of Science ®Google Scholar
• Shi Q, Moinuddin SM, Cai T. 2019. Advances in coamorphous drug delivery systems. Acta Pharm Sin B. 9(1):19–35.
   PubMed Web of Science ®Google Scholar
• Shi X, Song S, Ding Z, Fan B, Huang W, Xu T. 2019. Improving the solubility, dissolution, and bioavailability of ibrutinib by preparing it in a coamorphous state with saccharin. J Pharm Sci. 108(9):3020–3028.
   PubMed Web of Science ®Google Scholar
• Shimpi SL, Chauhan B, Mahadik KR, Paradkar A. 2005. Stabilization and improved in vivo performance of amorphous etoricoxib using Gelucire 50/13. Pharm Res. 22(10):1727–1734.
   PubMed Web of Science ®Google Scholar
• Soares FL, Carneiro RL. 2014. Evaluation of analytical tools and multivariate methods for quantification of co-former crystals in ibuprofen-nicotinamide co-crystals. J Pharm Biomed Anal. 89:166–175.
   PubMed Web of Science ®Google Scholar
• Tapas A, Kawtikwar P, Sakarkar D. 2012. An improvement in physicochemical properties of carvedilol through spherically agglomerated solid dispersions with PVP K30. Acta Pol Pharm. 69(2):299–308.
   PubMed Web of Science ®Google Scholar
• Turek M, Różycka-Sokołowska E, Koprowski M, Marciniak B, Bałczewski P. 2021. Role of hydrogen bonds in formation of co-amorphous valsartan/nicotinamide compositions of high solubility and durability with anti-hypertension and anti-covid-19 potential. Mol Pharm. 18(5):1970–1984.
   PubMed Web of Science ®Google Scholar
• von Mollendorff E, Reiff K, Neugebauer G. 1987. Pharmacokinetics and bioavailability of carvedilol, a vasodilating beta-blocker. Eur J Clin Pharmacol. 33(5):511–513.
   PubMed Web of Science ®Google Scholar
• Wang IC, Lee MJ, Sim SJ, Kim WS, Chun NH, Choi GJ. 2013. Anti-solvent co-crystallization of carbamazepine and saccharin. Int J Pharm. 450(1-2):311–322.
   PubMedGoogle Scholar
• Watanabe T, Wakiyama N, Usui F, Ikeda M, Isobe T, Senna M. 2001. Stability of amorphous indomethacin compounded with silica. Int J Pharm. 226(1-2):81–91.
   PubMedGoogle Scholar
• Wen X, Tan F, Jing Z, Liu Z. 2004. Preparation and study the 1:2 inclusion complex of carvedilol with beta-cyclodextrin. J Pharm Biomed Anal. 34(3):517–523.
   PubMed Web of Science ®Google Scholar
• Yokoi Y, Yonemochi E, Terada K. 2004. Changes in surface properties by granulation and physicochemical stability of granulated amorphous cefditoren pivoxil with additives. Int J Pharm. 280(1-2):67–75.
   PubMedGoogle Scholar